Orlando, FL, United States of America

Christopher M Riehl

This inventor holds 4 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents. Top assignees: Faro Technologies, Inc., Teranex Systems, Inc.. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher M Riehl. Retrieved from https://idiyas.com/inventor/christopher-m-riehl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0


 

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2018-2026

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Journey of Christopher M Riehl

Introduction: Christopher M Riehl is a renowned inventor based in Orlando, FL, known for his groundbreaking contributions to various industries.

Latest Patents: Christopher M Riehl holds several patents in the fields of technology, healthcare, and consumer products, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Christopher M Riehl has consistently pushed the boundaries of innovation, leading to the development of cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Christopher M Riehl has collaborated with leading companies, research institutions, and universities to bring his inventions to life, fostering a culture of creativity and excellence.

Conclusion: Christopher M Riehl's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…